Search details
1.
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.
Cell
; 174(3): 758-769.e9, 2018 07 26.
Article
in English
| MEDLINE | ID: mdl-30033370
2.
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.
Cell
; 175(3): 889, 2018 10 18.
Article
in English
| MEDLINE | ID: mdl-30340047
3.
Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol.
Future Oncol
; 20(12): 727-738, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38488039
4.
Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer.
Prostate
; 83(10): 912-921, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37071764
5.
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
Cancer
; 129(14): 2169-2178, 2023 07 15.
Article
in English
| MEDLINE | ID: mdl-37060201
6.
Poly(adenosine diphosphate-ribose) polymerase inhibitor combinations in first-line metastatic castrate-resistant prostate cancer setting: a systematic review and meta-analysis.
BJU Int
; 132(6): 619-630, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37461140
7.
Association of PSA kinetics after testosterone recovery with subsequent recurrence: secondary analysis of a phase III randomized controlled trial.
World J Urol
; 41(12): 3905-3911, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37792009
8.
Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption.
World J Urol
; 41(12): 3877-3887, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37851053
9.
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.
Proc Natl Acad Sci U S A
; 117(22): 12315-12323, 2020 06 02.
Article
in English
| MEDLINE | ID: mdl-32424106
10.
Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN): a randomized phase II study protocol.
Rep Pract Oncol Radiother
; 28(3): 379-388, 2023.
Article
in English
| MEDLINE | ID: mdl-37795393
11.
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.
Lancet Oncol
; 23(2): 304-316, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35051385
12.
Pan-cancer analysis of prognostic metastatic phenotypes.
Int J Cancer
; 150(1): 132-141, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-34287840
13.
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Prostate
; 82 Suppl 1: S73-S85, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35657158
14.
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results.
Cancer
; 128(7): 1513-1522, 2022 Apr 01.
Article
in English
| MEDLINE | ID: mdl-34985771
15.
Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate Cancer.
J Urol
; 207(3): 581-591, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34694160
16.
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.
J Urol
; 207(1): 127-136, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34433304
17.
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.
BMC Cancer
; 22(1): 494, 2022 May 05.
Article
in English
| MEDLINE | ID: mdl-35513774
18.
Development and validation of a life expectancy calculator for US patients with prostate cancer.
BJU Int
; 130(4): 496-506, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35373440
19.
Navigator-assisted hypofractionation (NAVAH) to address radiation therapy access disparities facing African-Americans with breast cancer.
Rep Pract Oncol Radiother
; 27(3): 583-588, 2022.
Article
in English
| MEDLINE | ID: mdl-36186700
20.
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis.
Lancet Oncol
; 22(3): 402-410, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33662287